Quality-control problems at a Baltimore plant manufacturing Covid-19 vaccines have led health officials on three continents to pause the distribution of millions of Johnson & Johnson doses, as the troubles of a politically connected U.S. contractor ripple across the world.
The U.S. vaccination campaign will soon expand to millions more people, but public health experts say the move raises complicated questions about supply and access.
President Biden and drugmakers are facing demands from liberal activists and global leaders to suspend intellectual property rights on the vaccines as the pandemic surges.
Scientists in Svalbard seeking to understand the environmental impact of releasing wastewater directly into the ocean have found surprisingly high levels of pharmaceuticals in crustaceans there.
Many scientists are expecting another rise in infections. But this time the surge will be blunted by vaccines and, hopefully, widespread caution. By summer, Americans may be looking at a return to normal life.
Two leading contenders generate wider debate about the leadership needed to restore morale and scientific integrity to an agency battered by the politicized Trump administration.
The new rules require testing soil, groundwater, and the septage or biosolid material being applied to the land for the presence of PFAS, ‘forever’ chemicals.
Marine toxicologists call for expanded testing of pharmaceuticals, as well as thousands of mystery chemicals, after a report cites "staggering" levels of contamination on the Great Barrier Reef.
The company scraps planned Pennsylvania investments and will instead shut down three polluting batteries in 2023. The announcement comes a week after a study shows lower lung function in people living near its Pittsburgh-region facility.
EHN.org scientific investigation finds western Pennsylvania families near fracking are exposed to harmful chemicals, and regulations fail to protect communities' mental, physical, and social health.
